AMERICAN EPILEPSY SOCIETY (EIN 046112600) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1954

Legal Domicile

Principal Officer

WENDY-JO TOYAMA

Phone

3128833800

Tax Period

2024-07-01 to 2025-06-30

AMERICAN EPILEPSY SOCIETY, founded in 1954, is a mid-sized nonprofit in the Diseases & Disorders sector that reported $11.9M in total revenue in fiscal year 2024. Revenue grew 14% year-over-year, indicating healthy expansion.

Mission

A COMMUNITY OF PHYSICIANS, SCIENTISTS, ADVANCED PRACTICE PROVIDERS, NURSES, PSYCHIATRISTS, PSYCHOLOGISTS, ENGINEERS, PHARMACISTS, ADVOCATES, AND OTHER PROFESSIONALS ENGAGED IN THE UNDERSTANDING, DIAGNOSIS, STUDY, PREVENTION, TREATMENT, AND CURE OF EPILEPSY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,636,436

Program Service Revenue $8,130,603

Investment Income $884,891

Other Revenue $226,197

TOTAL REVENUE $11,878,127

Expense Breakdown

Grants Paid $1,936,470

Salaries & Benefits $3,909,786

Fundraising Expenses $162,338

Program Expenses $10,296,488

Other Expenses $5,762,306

TOTAL EXPENSES $11,608,562

Year-over-Year Comparison

	2024	2023	Change
Revenue	$11,878,127	$10,460,621	+0.1%
Expenses	$11,608,562	$10,434,761	+0.1%
Net Income	$269,565	$25,860	+9.4%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

825

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$562,853

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
HOWARD P GOODKIN MD PHD FAES	PRESIDENT	5.00	Officer Director	$0	$0	$0
JACK M PARENT MD	FIRST VICE PRESIDENT	5.00	Officer Director	$0	$0	$0
DAVID M LABINER MD FAES	SECOND VICE PRESIDENT	5.00	Officer Director	$0	$0	$0
WILLIAM H THEODORE MD FAES	PRESIDENT EMERITUS	5.00	Officer Director	$0	$0	$0
FRED A LADO MD PHD FAES	TREASURER	5.00	Officer Director	$0	$0	$0
KELLY G KNUPP MD MSCS FAES	TREASURER ELECT	1.00	Director	$0	$0	$0
VIJI SANTHAKUMAR PHD	DIRECTOR	1.00	Director	$0	$0	$0
BARBARA C JOBST MD FAES	DIRECTOR	1.00	Director	$0	$0	$0
RENEE A SHELLHAAS MD MS FAES	DIRECTOR	1.00	Director	$0	$0	$0
BARRY E GIDAL PHARMD FAES	DIRECTOR	1.00	Director	$0	$0	$0
DAVID G VOSSLER MD FAES	DIRECTOR	1.00	Director	$0	$0	$0
EILEEN MURRAY	CEO UNTIL DEC 2024	45.00	Officer	$466,434	$35,374	$501,808
WENDY-JO TOYAMA MBA FASAE CAE	CEO SINCE NOV 2024	45.00	Officer	$58,974	$2,071	$61,045
JAMES POLOUS	DIRECTOR, TECHNOLOGY SOLUTIONS	40.00	Highest	$171,656	$31,508	$203,164
CHRISTINA GRAHAM	DIRECTOR, EDUCATION	40.00	Highest	$163,255	$37,443	$200,698
SHAWNA STRICKLAND	ASSOCIATE EXECUTIVE DIRECTOR	40.00	Highest	$223,016	$38,911	$261,927
JOY KELLER	SENIOR MANAGER, CLINICAL	40.00	Highest	$127,012	$28,272	$155,284
CHRISTINE MELENDES	ASSOCIATE EXECUTIVE DIRECTOR	40.00	Highest	$136,458	$5,615	$142,073

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$11,878,127	$11,608,562	$22,020,378	$269,565
2024	No data	No data	No data	No data
2023	$10,000,415	$9,832,791	$19,332,170	$167,624
2022	$9,656,912	$9,053,944	$17,665,869	$602,968
2021	$7,635,467	$6,624,221	$19,658,831	$1,011,246
2020	$10,909,273	$8,209,670	$16,187,204	$2,699,603
2019	$8,572,058	$8,026,858	$12,953,765	$545,200
2018	$8,428,401	$7,653,296	$12,148,842	$775,105

AMERICAN EPILEPSY SOCIETY